Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis

Stopped early · Not applicable

Conditions studied: Stage III Ovarian Cancer, Stage IV Ovarian Cancer

In brief

This research study is studying a possible test which may help doctors diagnose women with ovarian cancer.

Key facts

Study ID

NCT02441140

Run by

Dana-Farber Cancer Institute

People needed

5

Starts

2015-05-01

Expected to finish

2019-07-01

Last updated by the study team

2020-05-04

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female
• Age ≥ 18
• Able to give informed consent
• Scheduled for surgery at Brigham and Women's Hospital for known or highly suspected Stage III or IV ovarian cancer (i.e. elevated CA-125 with a pelvic mass, ascites, and carcinomatosis)
• Post-menopausal or negative urine and/or blood pregnancy test
• Measurable disease on preoperative imaging

You may not qualify if…

• Male
• Age < 18
• Unable to give informed consent
• Not planned for surgical intervention
• Active malignancy other than ovarian cancer
• Prior bilateral tubal ligation or hysterectomy (as this would prevent chromopertubation)
• Known or suspected active pelvic infection
• Pregnancy
• No measurable disease or suspected Stage I or II ovarian cancer on preoperative imaging

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States
• Dana Farber Cancer Institute — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.